Evidence map›Paper›PMID 30114270›Full record

ArticlePloS one2018

In vivo distribution of U87MG cells injected into the lateral ventricle of rats with spinal cord injury.

Jeong-Seob Won, Hyun Nam, Hye Won Lee, Ji-Yoon Hwang, Yu-Jeong Noh, Do-Hyun Nam, Sun-Ho Lee, Kyeung Min Joo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jeong-Seob WonDepartment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.
Hyun NamSingle Cell Network Research Center, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Hye Won LeeSingle Cell Network Research Center, Sungkyunkwan University School of Medicine, Suwon, South Korea.ORCID 0000-0002-0303-4658
Ji-Yoon HwangSingle Cell Network Research Center, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Yu-Jeong NohSingle Cell Network Research Center, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Do-Hyun NamDepartment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.
Sun-Ho LeeDepartment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.
Kyeung Min JooDepartment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.ORCID 0000-0003-2750-405X
Samsung Medical Center · KRSungkyunkwan University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cells could be the next generation therapeutic option for neurodegenerative diseases including spinal cord injury (SCI). However, several critical factors such as delivery method should be determined before their clinical applications. Previously, we have demonstrated that lateral ventricle (LV) injection as preclinical simulation could be used for intrathecal administration in clinical trials using rodent animal models. In this study, we further analyzed in vivo distribution of cells that were injected into LVs of rats with SCI at thoracic level using in vivo imaging techniques. When 5 × 106 U87MG cells labelled with fluorescent magnetic nanoparticle (FMNP-labelled U87MG) were administrated into LVs at 7 days after SCI, FMNP-labelled U87MG cells were observed in all regions of the spinal cord at 24 hours after the injection. Compared to water-soluble Cy5.5 fluorescent dye or rats without SCI, in vivo distribution pattern of FMNP-labelled U87MG cells was not different, although migration to the spinal cord was significantly reduced in both Cy5.5 fluorescent dye and FMNP-labelled U87MG cells caused by the injury. The presence of FMNP-labelled U87MG cells in the spinal cord was confirmed by quantitative PCR for human specific sequence and immunohistochemistry staining using antibody against human specific antigen. These data indicate that LV injection could recapitulate intrathecal administration of stem cells for SCI patients. Results of this study might be applied further to the planning of optimal preclinical and clinical trials of stem cell therapeutics for SCI.

Indexed as

Cell- and Tissue-Based TherapyInjections, IntraventricularLateral VentriclesAnimalsCell Line, TumorCell MovementDisease Models, AnimalFemaleFluorescent DyesHumansMagnetite NanoparticlesOptical ImagingRats, Sprague-DawleySpinal CordSpinal Cord InjuriesFluorescent DyesMagnetite Nanoparticles

Identifiers

PMID30114270
PMCPMC6095526
OpenAlexW2886799285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.